CAELYX PEGYLATED LIPOSOMAL
2MG/ML INF CNC SOL 1X10ML
Announcement of launch, break or close-out of marketing of a medicinal product
| Type of announcement | Effective date | Alternate medicines ? | Reason for interruption/cessation of marketing | Estimated renewal date |
|---|---|---|---|---|
| Cessation of marketing | 01.12.2010 |
0139063, 0139065, 0139066, 0042267, 0042270 |
||
| Interruption of marketing | 31.05.2012 | lék se stejnými indikacemi | ||
| Resumption of marketing | 19.12.2011 | |||
| Interruption of marketing | 08.12.2011 | lék v jiné lékové formě | ||
| Placing on the market | 01.01.2011 | |||
| Resumption of marketing | 09.09.2010 | |||
| Interruption of marketing | 02.09.2010 |
0107681, 0107682, 0122067, 0042267, 0042270 |
All reports are available in the Overview.
cz